Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. ASCO Updates Platelet Transfusion Guideline Prophylaxis unnecessary for adults undergoing HSCT

    ... stem-cell transplants (HSCT) may safely delay platelet infusion until the first sign of bleeding, as opposed to ... infusion, according to an updated guideline for platelet transfusion in patients with cancer. The recommendation, which ...

    Research Article last updated 12/06/2017 - 11:23am.

  2. Development and validation of a model to predict platelet response to romiplostim in patients with lower-risk myelodysplastic syndromes

    ... between endogenous thrombopoietin (THPO) levels and platelet response to romiplostim is unknown. Variables including baseline endogenous THPO levels, transfusion needs, and platelet response were analysed in a randomized trial of 250 thrombocytopenic, ...

    Research Article last updated 08/04/2014 - 8:33am.

  3. Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS

    ... syndromes (MDS) are not defined. Doubling of platelet count at start of second cycle of azacitidine therapy compared to ... follow-up. We found a significant association between platelet count doubling after first cycle of azacitidine therapy and ...

    Research Article last updated 08/04/2014 - 8:37am.

  4. Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia

    ... by 3 months after treatment, accompanying an increase in platelet counts, but stabilized at levels higher than normal. An inverse correlation was noted between TPO levels and platelet counts. The increased plasma TPO levels could be required to maintain ...

    Research Article last updated 10/23/2017 - 11:19am.

  5. Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia

    ... by 3 months post treatment accompanying an increase in platelet counts, but stabilized at the levels higher than normal range. An inverse correlation was noted between TPO levels and platelet counts. The increased plasma TPO levels could be required to maintain ...

    Research Article last updated 10/02/2017 - 9:40am.

  6. Decreased plasma cytokines associate with low platelet counts in aplastic anemia and immune thrombocytopenic purpura

    ... anemia (AA) patients and to be correlated with the platelet count. Objectives: To study the association of CD40L, CXCL5, ... proteins were significantly greater in patients with higher platelet counts than in those with lower platelet counts. In a murine ...

    Research Article last updated 07/30/2012 - 1:53pm.

  7. Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience

    ... response (p=0.03). By multivariate analysis, baseline platelet and lymphocyte count predicted for IST response at 3 and 6 ...

    Research Article last updated 09/13/2017 - 7:40am.

  8. Platelet drug shows clinical benefits for severe, unresponsive aplastic anemia

    ... well as stimulate increased production of platelets from platelet precursor cells. How is it given and for how long? ...

    Interview last updated 07/06/2012 - 3:42pm.

  9. Jill Minden’s Encounter with Aplastic Anemia

    ... turned into hospitals, weekly red blood cell and platelet transfusions, and lots of fear. I was treated at Barnes Jewish ...

    Patient Chronicle last updated 09/05/2017 - 10:57am.

  10. Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy

    ... Romiplostim can improve platelet counts in about 50% of patients with low- or intermediate 1-risk ... of romiplostim in 60 patients with lower risk MDS and platelet counts ≤50 × 109 /l. The primary endpoint was adverse event (AE) ...

    Research Article last updated 07/11/2017 - 10:22am.